Long-term maintenance ribavirin monotherapy in chronic hepatitis C patients not responding or intolerant to interferon alpha

被引：2
|
作者：
Trepo, C.
Bonaventure, C.
Calay, V.
Chevallier, M.
Merle, P.
Pradat, P.
机构：
[1] Hop Hotel Dieu, Liver Unit, F-69288 Lyon, France
[2] Inst Pasteur, Dept Pathol, Lab Marcel Merieux, Lyon, France
来源：
JOURNAL OF CLINICAL VIROLOGY | 2006年 / 36卷
关键词：
D O I：
10.1016/S1386-6532(06)80122-8
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [21] Recovery from chronic hepatitis C in long-term responders to ribavirin plus interferon alfa
    Fontaine, H
    Chaix, ML
    Lagneau, JL
    Bréchot, C
    Pol, S
    LANCET, 2000, 356 (9223): : 41 - 41
  • [22] Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Chiodo, F
    Magliano, E
    Furione, L
    Idéo, G
    JOURNAL OF HEPATOLOGY, 2000, 33 (03) : 463 - 468
  • [23] High-dose interferon plus ribavirin in chronic hepatitis C not responding to recombinant alpha-interferon
    Bresci, G
    Parisi, G
    Bertoni, M
    Capria, A
    DIGESTIVE AND LIVER DISEASE, 2000, 32 (08) : 703 - 707
  • [24] Combination of interferon alpha and ribavirin in chronic hepatitis C non responders to interferon monotherapy: Role of genotype and age
    Fargion, S
    Bruno, S
    Borzio, M
    Bissoli, F
    Zuin, M
    Orlandi, A
    Battezzati, P
    Maraschi, A
    Chiesa, A
    Fiorelli, G
    Podda, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 205 - 205
  • [25] A long-term response to alpha-interferon and ribavirin in hepatitis C is maintained in patients with a sustained response to treatment.
    Barnes, EJ
    Webster, GM
    Jacobs, RS
    Brown, DJ
    Whalley, SA
    Dusheiko, GM
    HEPATOLOGY, 1999, 30 (04) : 270A - 270A
  • [26] The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan
    Hiramatsu, N
    Kasahara, A
    Nakanishi, F
    Toyama, T
    Tsujii, M
    Tsuji, S
    Kanto, T
    Takehara, T
    Kato, M
    Yoshihara, H
    Naito, M
    Katayama, K
    Hijioka, T
    Hagiwara, H
    Kubota, S
    Oshita, M
    Meren, H
    Masuzawa, M
    Haruna, Y
    Mita, E
    Suzuki, K
    Hayashi, N
    HEPATOLOGY RESEARCH, 2004, 29 (03) : 142 - 147
  • [27] Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin
    Overbeck, Kathrin
    Genne, Daniel
    Golay, Alain
    Negro, Francesco
    JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 295 - 298
  • [28] Long-term biochemical and virological response to natural interferon-alpha in patients with chronic hepatitis C
    Hagiwara, H
    Hayashi, N
    Kasahara, A
    Oshita, M
    Katayama, K
    Naito, M
    Masuzawa, M
    Yoshihara, H
    Shimizu, Y
    Fusamoto, H
    Kamada, T
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (05) : 1001 - 1007
  • [29] Long-term outcomes of chronic hepatitis C patients treated with pegylated interferon 2a plus ribavirin in Iran
    Alavian, Seyed Moayed
    Menati, Majid
    Shabani, Mahtab
    Shafiei, Mostafa
    Nejad, Mohammad Kolbadi
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2012, 6 (20): : 4298 - U246
  • [30] Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone
    Puoti, M
    Cadeo, GP
    Putzolu, V
    Forleo, MA
    Barni, MC
    Cristini, G
    Rossi, S
    Spinetti, A
    Zaltron, S
    Zanini, B
    Quiros-Roldan, E
    Paraninfo, G
    Gargiulo, F
    Carosi, G
    DIGESTIVE AND LIVER DISEASE, 2001, 33 (02): : 163 - 172
12345